Tatva Chintan Pharma Chem Ltd held an earnings call on October 31, 2025, discussing financial results for the quarter ended September 30, 2025, which showed a 48% year-on-year growth in revenue to INR 1,235 million and a 298% growth in EBITDA to INR 222 million.